浅刺针法治疗脑干梗死的疗效评价及脑功能网络机制研究

注册号:

Registration number:

ITMCTR2024000456

最近更新日期:

Date of Last Refreshed on:

2024-09-19

注册时间:

Date of Registration:

2024-09-19

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

浅刺针法治疗脑干梗死的疗效评价及脑功能网络机制研究

Public title:

Shallow Acupuncture in the Treatment of Brainstem Infarction: A Single-center Randomized Controlled Study and fMRI Analysis

注册题目简写:

English Acronym:

研究课题的正式科学名称:

浅刺针法治疗脑干梗死的疗效评价及脑功能网络机制研究

Scientific title:

Shallow Acupuncture in the Treatment of Brainstem Infarction: A Single-center Randomized Controlled Study and fMRI Analysis

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

左鸿歌

研究负责人:

徐振华

Applicant:

Hongge Zuo

Study leader:

Zhenhua Xu

申请注册联系人电话:

Applicant telephone:

13640672585

研究负责人电话:

Study leader's telephone:

13533069416

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

879381859@qq.com

研究负责人电子邮件:

Study leader's E-mail:

xzh197011@163.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

广东省广州市越秀区大德路111号

研究负责人通讯地址:

广东省广州市越秀区大德路111号

Applicant address:

No. 111 Dade Road Yuexiu District Guangzhou City Guangdong Province

Study leader's address:

No. 111 Dade Road Yuexiu District Guangzhou City Guangdong Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

广东省中医院

Applicant's institution:

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

YE2024-203-01

伦理委员会批件附件:

Approved file of Ethical Committee:

查看附件

批准本研究的伦理委员会名称:

广东省中医院伦理委员会

Name of the ethic committee:

Ethics Committee of Guangdong Provincial Hospital of Traditional Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2024/6/21 0:00:00

伦理委员会联系人:

李晓彦

Contact Name of the ethic committee:

Xiaoyan Li

伦理委员会联系地址:

广东省广州市越秀区大德路111号

Contact Address of the ethic committee:

No. 111 Dade Road Yuexiu District Guangzhou City Guangdong Province

伦理委员会联系人电话:

Contact phone of the ethic committee:

020-81887233转35943

伦理委员会联系人邮箱:

Contact email of the ethic committee:

llbgs@gzucm.edu.cn

研究实施负责(组长)单位:

广东省中医院

Primary sponsor:

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine

研究实施负责(组长)单位地址:

广东省广州市越秀区大德路111号

Primary sponsor's address:

No. 111 Dade Road Yuexiu District Guangzhou City Guangdong Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

广东省

市(区县):

广州市

Country:

China

Province:

Guangdong Province

City:

Guangzhou

单位(医院):

广东省中医院

具体地址:

广东省广州市越秀区大德路111号

Institution
hospital:

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine

Address:

No. 111 Dade Road Yuexiu District Guangzhou City Guangdong Province

经费或物资来源:

自筹

Source(s) of funding:

Self support

研究疾病:

脑干梗死

研究疾病代码:

Target disease:

Brainstem Infarction

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

其它

Others

研究目的:

1.总结脑干梗死患者的中医证候特征,为中医证候规范化及穴位处方学研究提供参考依据。 2.观察浅刺针法治疗脑干梗死的临床疗效,为临床实践提供循证医学证据。 3.探究针刺治疗脑干梗死的脑功能网络机制,为临床应用提供科学理论依据。

Objectives of Study:

1.To summarize the characteristics of TCM syndromes in patients with brainstem infarction and to provide reference for the standardization of TCM syndromes. 2.To observe the clinical efficacy of shallow acupuncture in the treatment of brainstem infarction and to provide evidence-based medical evidence for clinical practice. 3.To explore the brain function network mechanism of acupuncture in the treatment of brainstem infarction and to provide scientific theoretical basis for clinical application.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

(1)符合《缺血性卒中基层诊疗指南(2021年)》及《中国缺血性卒中和短暂性脑缺血发作二级预防指南 2022》中脑梗死的诊断,并且经头颅MRI检查后最终确诊为脑干梗死。 (2)无性别限制,年龄范围为30~80岁,首次发病且病程在6个月内; (3)患者病情基本稳定,无意识障碍,认知功能正常; (4)自愿签署知情同意书; (5)现未处于其他临床研究之中。

Inclusion criteria

1.Conform to the diagnostic criteria of cerebral infarction and confirmed by brain MRI examination for brainstem infarction 2.The age range was 30-80 years old. The first onset of the disease and the course of the disease were within 6 months 3.The patient 's condition was basically stable with unconscious disorder and normal cognitive function 4.Signing informed consent 5.It is not currently in other clinical studies

排除标准:

(1)有脑干以外部位新发梗死灶者; (2)妊娠期女性,恶性肿瘤晚期,既往脑部手术,既往癫痫、脑肿瘤等其他中枢神经系统疾病史等; (3)存在精神障碍,严重心、肺、肝、肾功能损伤,严重凝血功能障碍,病情危重或生命体征不稳定者; (4)因取穴皮肤处有破损不宜施针及不能配合完成检查的患者。

Exclusion criteria:

1.Patients with acute cerebral infarction other parts other than the brainstem 2.Pregnant women advanced malignant tumors previous brain surgery previous history of epilepsy brain tumors and other central nervous system diseases 3.Patients with mental disorders severe heart lung liver and kidney function damage severe coagulation dysfunction critical illness or unstable vital signs 4.Patients who could not complete acupuncture treatment

研究实施时间:

Study execute time:

From 2024-09-01

To      2026-09-01

征募观察对象时间:

Recruiting time:

From 2024-10-10

To      2026-06-01

干预措施:

Interventions:

组别:

浅刺针法组

样本量:

31

Group:

Shallow acupuncture group

Sample size:

干预措施:

浅刺针法

干预措施代码:

Intervention:

Shallow acupuncture

Intervention code:

组别:

常规针刺组

样本量:

31

Group:

Traditional acupuncture group

Sample size:

干预措施:

常规针刺

干预措施代码:

Intervention:

Traditional acupuncture

Intervention code:

样本总量 Total sample size : 62

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

广东省

市(区县):

广州市

Country:

China

Province:

Guangdong Province

City:

Guangzhou

单位(医院):

广东省中医院

单位级别:

三级甲等

Institution/hospital:

The Second Affiliated Hospital of Guangzhou University of Chinese Medicine

Level of the institution:

Third-grade class-A

测量指标:

Outcomes:

指标中文名:

日常生活活动能力量表

指标类型:

主要指标

Outcome:

Barthel Index

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

美国国立卫生研究院卒中量表

指标类型:

次要指标

Outcome:

NIHSS

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

POST-NIHSS评分

指标类型:

次要指标

Outcome:

POST-NIHSS

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

征募研究对象情况:

尚未开始

Not yet recruiting

年龄范围:

最小 30
Min age years
最大 80
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

由第三方人员使用统计学软件产生随机数字表并制作成随机卡

Randomization Procedure (please state who generates the random number sequence and by what method):

A random number table was generated by a third party using statistical software and made into a random card

盲法:

Blinding:

是否共享原始数据:

IPD sharing:

No

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

临床试验公共管理平台 ResMan, http://www.medresman.org.cn.

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

ResMan, http://www.medresman.org.cn.

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

数据包括原始记录、病例记录表等数据的excel保存,使用EDC数据库管理。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

The data includes the using excel records of CRF. TheEDC database will be used.

数据管理委员会:

Data Managemen Committee:

Yes

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

国际传统医学临床试验注册平台 京ICP备07032215号-5 提示:推荐使用IE8.0以上版本 宽屏显示分辨率下使用系统